Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

A Case Series of Acquired Drug Resistance-Associated Mutations in Human Immunodeficiency Virus-Infected Children: An Emerging Public Health Concern in Rural Africa.

Gamell A, Muri L, Ntamatungiro A, Nyogea D, Luwanda LB, Hatz C, Battegay M, Felger I, Tanner M, Klimkait T, Letang E.

Open Forum Infect Dis. 2015 Dec 17;3(1):ofv199. doi: 10.1093/ofid/ofv199. eCollection 2016 Jan.

2.

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.

Musoke P, Szubert AJ, Musiime V, Nathoo K, Nahirya-Ntege P, Mutasa K, Williams DE, Prendergast AJ, Spyer M, Walker AS, Gibb DM; ARROW Trial Team.

AIDS. 2015 Aug 24;29(13):1623-32. doi: 10.1097/QAD.0000000000000749.

3.

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.

Mutwa PR, Boer KR, Asiimwe-Kateera B, Tuyishimire D, Muganga N, Lange JM, van de Wijgert J, Asiimwe A, Reiss P, Geelen SP.

PLoS One. 2014 Nov 3;9(11):e111948. doi: 10.1371/journal.pone.0111948. eCollection 2014.

4.

Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team.

Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.

5.

Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.

Collins IJ, Judd A, Gibb DM.

Curr Opin HIV AIDS. 2014 Jan;9(1):87-94. doi: 10.1097/COH.0000000000000027. Review.

6.

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.

Picat MQ, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, Nahirya Ntege P, Gibb DM, Thiebaut R, Walker AS, Klein N, Callard R; ARROW Trial Team.

PLoS Med. 2013 Oct;10(10):e1001542. doi: 10.1371/journal.pmed.1001542. Epub 2013 Oct 29.

7.

Immunology of pediatric HIV infection.

Tobin NH, Aldrovandi GM.

Immunol Rev. 2013 Jul;254(1):143-69. doi: 10.1111/imr.12074. Review.

8.

The role of etravirine in the management of treatment-experienced pediatric patients with HIV.

Osterholzer D.

HIV AIDS (Auckl). 2013 Apr 10;5:67-73. doi: 10.2147/HIV.S32324. Print 2013.

9.
10.

Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment.

Cotugno N, Douagi I, Rossi P, Palma P.

Clin Dev Immunol. 2012;2012:805151. doi: 10.1155/2012/805151. Epub 2012 Apr 8. Review.

11.

Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.

Judd A; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord.

AIDS. 2011 Nov 28;25(18):2279-87. doi: 10.1097/QAD.0b013e32834d614c.

12.

Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda.

Kay J, Wanzira H, Sandison T, Kakuru A, Bigira V, Kamya M, Homsy J, Tappero JW, Havlir D, Dorsey G, Ruel T.

J Trop Pediatr. 2012 Jun;58(3):194-9. doi: 10.1093/tropej/fmr071. Epub 2011 Sep 19.

13.

Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana.

Renner L, Prin M, Li FY, Goka B, Northrup V, Paintsil E.

AIDS Res Treat. 2011;2011:896040. doi: 10.1155/2011/896040. Epub 2011 May 11.

14.

Risk of triple-class virological failure in children with HIV: a retrospective cohort study.

Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Castro H, Judd A, Gibb DM, Butler K, Lodwick RK, van Sighem A, Ramos JT, Warsawski J, Thorne C, Noguera-Julian A, Obel N, Costagliola D, Tookey PA, Colin C, Kjaer J, Grarup J, Chene G, Phillips A.

Lancet. 2011 May 7;377(9777):1580-7. doi: 10.1016/S0140-6736(11)60208-0. Epub 2011 Apr 20.

15.

Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries.

Peacock-Villada E, Richardson BA, John-Stewart GC.

Pediatrics. 2011 Feb;127(2):e423-41. doi: 10.1542/peds.2009-2701. Epub 2011 Jan 24. Review.

16.

Treatment and disease progression in a birth cohort of vertically HIV-1 infected children in Ukraine.

Mahdavi S, Malyuta R, Semenenko I, Pilipenko T, Thorne C; Ukraine European Collaborative Study Group.

BMC Pediatr. 2010 Nov 23;10:85. doi: 10.1186/1471-2431-10-85.

17.

Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe.

Ferrand RA, Munaiwa L, Matsekete J, Bandason T, Nathoo K, Ndhlovu CE, Munyati S, Cowan FM, Gibb DM, Corbett EL.

Clin Infect Dis. 2010 Oct 1;51(7):844-51. doi: 10.1086/656361.

18.

Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis.

Reitz C, Coovadia A, Ko S, Meyers T, Strehlau R, Sherman G, Kuhn L, Abrams EJ.

J Infect Dis. 2010 Apr 15;201(8):1121-31. doi: 10.1086/651454.

19.

Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey.

Ferrand RA, Bandason T, Musvaire P, Larke N, Nathoo K, Mujuru H, Ndhlovu CE, Munyati S, Cowan FM, Gibb DM, Corbett EL.

PLoS Med. 2010 Feb 2;7(2):e1000178. doi: 10.1371/journal.pmed.1000178.

20.

Bridging the gap between adult and paediatric outcomes in HIV-1 vertically infected children: a single-centre comparison with adult data.

Monpoux F, Pugli├Ęse P, Berthier F, Cottalorda J, Pradier C.

Acta Paediatr. 2009 Nov;98(11):1787-92. doi: 10.1111/j.1651-2227.2009.01440.x. Epub 2009 Aug 4.

Items per page

Supplemental Content

Write to the Help Desk